Dova Pharmaceuticals Inc (DOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 104,566 | 94,846 | 28,709 |
| Receivables | 612 | N/A | N/A |
| Inventories | 4,390 | N/A | N/A |
| TOTAL | $111,807 | $96,317 | $28,746 |
| Non-Current Assets | |||
| PPE Net | 362 | 62 | N/A |
| TOTAL | $362 | $62 | $N/A |
| Total Assets | $112,169 | $96,379 | $28,746 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 6,667 | N/A | N/A |
| Accounts payable and accrued liabilities | 816 | 1,360 | 242 |
| Accrued Expenses | 12,014 | 3,525 | 8,069 |
| Other current liabilities | N/A | 100 | N/A |
| TOTAL | $19,497 | $35,197 | $8,311 |
| Non-Current Liabilities | |||
| Long Term Debt | 13,941 | N/A | 13,640 |
| TOTAL | $16,314 | $N/A | $13,640 |
| Total Liabilities | $35,811 | $35,197 | $21,951 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 28,227 | 25,679 | N/A |
| Common Shares | 28 | 26 | 17 |
| Retained earnings | -129,427 | -57,145 | -27,190 |
| TOTAL | $76,358 | $61,182 | $6,795 |
| Total Liabilities And Equity | $112,169 | $96,379 | $28,746 |